|
US2009131377A1
|
|
Combinations of Superoxide Dismutase Mimetics and Nonsteroidal Analgesic/Anti-Inflammatory Drugs
|
|
WO2006078713A2
|
|
Methotrexate combinations for treating inflammatory diseases
|
|
WO2006083508A2
|
|
Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
|
|
CA2591970A1
|
|
Polyethylene glycolated superoxide dismutase mimetics
|
|
WO2006037050A2
|
|
Methods for treating congestive heart failure
|
|
WO2005060437A2
|
|
Composition combinations and methods for treating, preventing, reversing and inhibiting pain
|
|
WO2005041894A2
|
|
Compositions and methods for treating, preventing, reversing and inhibiting pain
|
|
WO2005041886A2
|
|
Methods for generating or increasing revenues related to pain inhibitor commerce
|
|
WO2005041885A2
|
|
Compositions and methods for treating, preventing, reversing and inhibiting pain
|
|
WO2005042718A2
|
|
Compositions and methods for treating, preventing, reversing and inhibiting pain
|
|
EP1412360A1
|
|
COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE
|
|
AU2002315001A1
|
|
Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
|
|
AU2002236861A1
|
|
Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
|
|
AU2002241807A1
|
|
Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
|
|
US2002128248A1
|
|
SODm therapy for prevention and/or treatment of inflammatory disease
|
|
US2002072512A1
|
|
Method of preventing and treating HIV-mediated central nervous system damage
|
